A trial in which rosiglitazone and glipizide were compared supports earlier findings that rosiglitazone does not have an adverse effect on the progression of coronary atherosclerosis ...
Objective: Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either ...
[37] Metformin is available in combination with the following agents: rosiglitazone (Avandamet®), pioglitazone (Actoplus Met®), glipizide (Metaglip®), glibenclamide (Glucovance®), sitagliptin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results